UHSD2 - Overview: Hemosiderin, Random, Urine
Detecting hemosiderinuria, secondary to excess hemolysis, as in incompatible blood transfusions, severe acute hemolytic anemia, or hemochromatosis for external patients.
EEEVI - Overview: Red Blood Cell (RBC) Enzyme Interpretation
Interpretation of results for the red blood cell enzyme evaluation Identifying defects of red cell enzyme metabolism Evaluating patients with Coombs-negative hemolytic anemia
GNPRC - Overview: Protein C Deficiency, PROC Gene, Next-Generation Sequencing, Varies
Evaluating protein C deficiency in patients with a personal or family history suggestive of this hereditary thrombophilia Confirming a diagnosis of autosomal dominant protein C deficiency with the identification of a known or suspected...
GNPLT - Overview: Platelet Disorders, Comprehensive Gene Panel, Next-Generation Sequencing, Varies
Evaluating hereditary platelet disorders in patients with a personal or family history suggestive of a hereditary platelet disorder Diagnosing hereditary platelet disorders for patients in whom phenotypic testing is nondiagnostic, but...
GNPRS - Overview: Protein S Deficiency, PROS1 Gene, Next-Generation Sequencing, Varies
Evaluating protein S deficiency in patients with a personal or family history suggestive of this hereditary thrombophilia Confirming a diagnosis of autosomal dominant protein S deficiency with the identification of a known or suspected...
GNPFD - Overview: Platelet Function Defect Gene Panel, Next-Generation Sequencing, Varies
Diagnosing hereditary platelet function defect disorders for patients who have a distinct platelet function defect pattern, such as Bernard-Soulier syndrome, revealed by laboratory phenotypic testing Confirming a hereditary platelet...
GNHTC - Overview: Hereditary Thrombocytopenia Gene Panel, Next-Generation Sequencing, Varies
Evaluating hereditary thrombocytopenia disorders in patients with a personal or family history suggestive of a hereditary thrombocytopenia disorder Diagnosing hereditary thrombocytopenia disorders for patients in whom phenotypic testing is...
MEV0 - Overview: Methemoglobin Summary Interpretation
Incorporating and summarizing subsequent results into an overall interpretation for the MEV1 / Methemoglobinemia Evaluation, Blood
ALT - Overview: Alanine Aminotransferase (ALT) (GPT), Serum
Diagnosis and monitoring of liver disease associated with hepatic necrosis
UOSMS - Overview: Osmolality, Serum
Evaluating acutely ill or comatose patients
Diagnosis of COVID-19 illness due to SARS-CoV-2
ADNA1 - Overview: Double-Stranded DNA (dsDNA) Antibodies, IgG, Serum
Evaluating patients with clinical features or at-risk for systemic lupus erythematosus (SLE) Monitoring disease activity, as an adjunct test, in patients with SLE previously positive for double-stranded DNA IgG antibodies
NSAI - Overview: Neurosyphilis IgG, Antibody Index, Spinal Fluid
Aid in the diagnosis of neuroinvasive syphilis as part of a profile
ACLIP - Overview: Phospholipid (Cardiolipin) Antibodies, IgA, Serum
May be of diagnostic significance for patients at risk for antiphospholipid syndrome or systemic lupus erythematosus who test negative for criterial antiphospholipid antibodies
ALB - Overview: Albumin, Serum
Assessing nutritional status
OXYMU - Overview: Oxymorphone Confirmation, Random, Urine
Detection and quantification of oxymorphone and noroxymorphone in urine
TOBPA - Overview: Tobramycin, Peak, Serum
Monitoring adequacy of serum concentration during tobramycin therapy
UOSMU - Overview: Osmolality, Random, Urine
Assessing the concentrating and diluting ability of the kidney
PFN - Overview: Propafenone, Serum
Monitoring propafenone therapy Assessing potential propafenone toxicity
TPSF - Overview: Protein, Total, Spinal Fluid
Detecting disruptions of the blood-brain barrier or intrathecal synthesis of immunoglobulins
KS - Overview: Potassium, Serum
Evaluation of electrolyte balance, cardiac arrhythmia, muscular weakness, hepatic encephalopathy, and renal failure
LITH - Overview: Lithium, Serum
Monitoring therapy of patients with bipolar disorders, including recurrent episodes of mania and depression Evaluating lithium toxicity
MEX - Overview: Mexiletine, Serum
Assessing achievement of optimal therapeutic mexiletine concentrations Assessing potential mexiletine toxicity
MDNS - Overview: Methadone and Metabolites, Serum
Compliance monitoring of methadone Assessment of methadone toxicity
FLEC - Overview: Flecainide, Serum
Optimizing flecainide dosage Assessing flecainide toxicity Monitoring compliance
SDEX - Overview: Sickle Solubility, Blood
Screening for presence or absence of hemoglobin (Hb) S (sickle cell disease)
HCO3 - Overview: Bicarbonate, Serum
Diagnosis and treatment of acid-base imbalance in respiratory and metabolic systems
HYDCU - Overview: Hydrocodone with Metabolite Confirmation, Random, Urine
Detection and quantification of hydrocodone, norhydrocodone, and hydromorphone in urine
5BETH - Overview: Factor V Bethesda Units, Plasma
Detecting and quantifying the presence and titer of a specific factor inhibitor directed against coagulation factor V
Assessing acid-base balance, water balance, water intoxication, and dehydration
LNBAI - Overview: Lyme Central Nervous System Infection IgG, Antibody Index, Spinal Fluid
Providing antibody index information to aid in the diagnosis of neuroinvasive Lyme disease or neuroborreliosis due to Borrelia species associated with Lyme disease (eg, Borrelia burgdorferi, Borrelia garinii, Borrelia afzelli)
GNMTC - Overview: Macro/Microthrombocytopenia Gene Panel, Next-Generation Sequencing, Varies
Evaluating hereditary macro- or microthrombocytopenia disorders in patients with a personal or family history suggestive of a hereditary macro- or microthrombocytopenia disorder Diagnosing hereditary macro- or microthrombocytopenia...
GNMY9 - Overview: MYH9-Related Disorders, MYH9 Gene, Next-Generation Sequencing, Varies
Evaluating MYH9-related disorders, including May-Hegglin disorder/anomaly and Sebastian syndrome, in patients with a personal or family history suggestive of an MYH9-related disorder Diagnosing MYH9-related disorders, including May-Hegglin...
HAEV0 - Overview: Hemolytic Anemia Summary Interpretation
Incorporating and summarizing subsequent results into an overall interpretation for the HAEV1 / Hemolytic Anemia Evaluation, Blood
F_9 - Overview: Coagulation Factor IX Activity Assay, Plasma
Diagnosing deficiencies, particularly hemophilia B (Christmas disease) Assessing the impact of liver disease on hemostasis Investigation of a prolonged activated partial thromboplastin time
PTSC - Overview: Prothrombin Time (PT), Plasma
Screening to identify a deficiency of one or more of the clotting factors of the extrinsic coagulation system (I, II, V, VII, X) due to hereditary deficiency or acquired conditions such as liver disease, vitamin K deficiency, or a specific...
PTMSC - Overview: Prothrombin Time Mix 1:1, Plasma
Screening test to detect a deficiency of 1 or more of the clotting factors of the extrinsic coagulation system (I, II, V, VII, X) due to hereditary deficiency or acquired conditions such as liver disease, vitamin K deficiency, or a specific...
INS - Overview: Insulin, Serum
Diagnosing insulinoma, when used in conjunction with proinsulin and C-peptide measurements Management of diabetes mellitus
URIC - Overview: Uric Acid, Serum
Diagnosis and treatment of renal failure Monitoring patients receiving cytotoxic drugs and a variety of other disorders, including gout, leukemia, psoriasis, starvation and other wasting conditions
GBETH - Overview: General Factor Bethesda Units, Plasma
Detecting and quantifying the presence and titer of a specific factor inhibitor directed against a specific coagulation factor
GENPA - Overview: Gentamicin, Peak, Serum
Monitoring adequacy of drug clearance during gentamicin therapy
GENRA - Overview: Gentamicin, Random, Serum
Monitoring adequacy of serum concentration during gentamicin therapy in specimens for which no collection timing information is provided
F_12 - Overview: Coagulation Factor XII Activity Assay, Plasma
Diagnosing deficiency of coagulation factor XII Determining cause of prolonged activated partial thromboplastin time
F_11 - Overview: Coagulation Factor XI Activity Assay, Plasma
Diagnosing deficiency of coagulation factor XI Investigating prolonged activated partial thromboplastin time
OSM24 - Overview: Osmolality, 24 Hour, Urine
Assessing the concentrating and diluting ability of the kidney using a 24-hour urine collection
F_7 - Overview: Coagulation Factor VII Activity Assay, Plasma
Diagnosing congenital deficiency of coagulation factor VII Evaluating acquired deficiencies associated with liver disease, oral anticoagulant therapy, and vitamin K deficiency Determining degree of anticoagulation with warfarin to...
F_10 - Overview: Coagulation Factor X Activity Assay, Plasma
Diagnosing deficiency of coagulation factor X, congenital or acquired Evaluating hemostatic function in liver disease Investigation of prolonged prothrombin time or activated partial thromboplastin time
PHOS - Overview: Phosphorus (Inorganic), Serum
Diagnosis and management of a variety of disorders including bone, parathyroid, and kidney disease
6MAMU - Overview: 6-Monoacetylmorphine Confirmation, Random, Urine
Determination of heroin use
PCPMC - Overview: Phencyclidine (PCP) Confirmation, Meconium
Detection of in utero to phencyclidine (PCP) exposure up to 5 months before birth
Since the pandemic hit, she's spent a great deal of time vetting antibody tests and has set up a COVID-19 testing program at Mayo Clinic....
Staffing to Workload in Phlebotomy Areas: Off-Site Operational Needs - Insights
discusses staffing to workload in phlebotomy areas with a focus on off-site operational needs, including paid time off and unpaid time off....
practices from the program, Mayo Medical Laboratories collaborated with National Decision Support Company (NDSC) to combine Mayo’s clinical knowledge with NDSC’s industry-leading expertise in electronic...
Laboratory and pathology research roundup: August 30 - Insights
This week's research roundup features: Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis...
Visit Mayo Clinic Laboratories at the APA Annual Meeting - Insights
Visit Mayo Clinic Laboratories at booth #2047 to learn about our comprehensive therapeutics test offerings. Developed by board-certified experts in clinical chemistry, molecular, and toxicology testing...